Xtant Medical Holdings, Inc. (XTNT) Stock

Xtant Medical Holdings, Inc., headquartered in Belgrade, Montana, is a leading developer, manufacturer, and distributor of regenerative medicine products and medical devices catering to orthopedic and neurological surgeons globally. The company's extensive product portfolio includes innovative biomaterials such as OsteoSponge, designed to serve as a natural scaffold promoting cellular growth and bone-forming proteins' exposure in healing environments. Additionally, Xtant offers specialized solutions like OsteoSelect DBM Putty and OsteoSelect PLUS DBM Putty, utilized as bone graft substitutes and void fillers in various surgical applications, including the pelvis, extremities, and spine.

Complementing its biomaterial offerings, Xtant Medical Holdings provides 3Demin allografts, maximizing osteoconductivity and osteoinductive potential from human bone. The company also plays a crucial role in sports medicine through the distribution of allografts for ligament repairs and milled spinal allografts tailored to specific surgical requirements. Xtant further supports surgical needs across multiple disciplines with a range of spinal fixation systems such as Certex, Spider cervical plating, and innovative solutions like the Axle interspinous fusion and Xpress minimally, invasive pedicle screw systems.

Formerly known as Bacterin International Holdings, Xtant Medical Holdings underwent a transformative name change in July 2015, marking its commitment to advancing regenerative medicine technologies and expanding its global impact. With a steadfast dedication to innovation and quality, Xtant continues to redefine surgical possibilities and enhance patient outcomes in orthopedic and neurological practices worldwide.